Petros Pharmaceuticals ( (PTPI) ) just unveiled an announcement.
On April 10, 2025, Petros Pharmaceuticals held a Special Meeting where stockholders approved several key amendments to the company’s Certificate of Incorporation. These included increasing the number of authorized shares of Common Stock from 250 million to 7 billion and implementing a reverse stock split at a ratio to be determined by the Board. These changes are aimed at enhancing the company’s capital structure and flexibility, potentially impacting its market positioning and shareholder value.
More about Petros Pharmaceuticals
YTD Price Performance: -90.0%
Average Trading Volume: 35,649,556
Technical Sentiment Signal: Strong Buy
Current Market Cap: $2.77M
See more data about PTPI stock on TipRanks’ Stock Analysis page.